Kuros Biosciences AG Cash Flow Reinvestment Rate

Latest as of December 2025: 0.53x

Kuros Biosciences AG cash flow reinvestment rate. Kuros Biosciences AG (KURN) has a Cash Flow Reinvestment Rate of 0.53x as of December 2025, reinvesting CHF1.03 Million (capex CHF1.03 Million ) from operating cash flow of CHF1.94 Million. See Kuros Biosciences AG (KURN) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.53x

(Capex + Investments) / Operating CF

Total Reinvested

CHF1.03 Million

Capex + Investments

Operating Cash Flow

CHF1.94 Million

CHF

Capital Expenditures

CHF1.03 Million

CHF

Cash Flow Reinvestment Rate of Kuros Biosciences AG (2024–2024)

Cash flow reinvestment rate of Kuros Biosciences AG from 2024 to 2024. Historical reinvestment intensity for Kuros Biosciences AG across 1 annual periods. Explore Kuros Biosciences AG debt service capacity to assess how comfortably operating cash covers total debt obligations.

Kuros Biosciences AG Cash Flow Reinvestment Rate by Year (2024–2024)

Kuros Biosciences AG cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for Kuros Biosciences AG. For the full cash flow conversion analysis, see cash flow conversion of Kuros Biosciences AG.

Year	Reinvestment Rate	Total Reinvested (CHF)	Operating CF	Capex	YoY Change
2024	0.71x	CHF2.22 Million	CHF3.14 Million	CHF1.11 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow